Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Notable Labs Ltd
Healthcare
P/NCAV
0.2x
Ticker
NTBL
Exchange
NASDAQ
Country
United States
Close
0.99 $
Mkt Cap
2.2M $
EV
-9.3M $
NCAV Burn Rate
26.1%
Current Ratio
5.65
Debt/Equity
0.02
EV/REV
-29.93x
EV/EBIT
N/Ax
EV/FCF
0.7x
Dilution
19.6% p.A
Total Net Income
-184.8M $
Cheapness
99.0%
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company-s product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average